Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review.

Szczegóły
Abstrakt

Tytuł:: Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review.
Autorzy:: Gonçalves V; Centre for Health Studies and Research of the University of Coimbra (CEISUC), Faculty of Economics, University of Coimbra, Coimbra, Portugal.
Ferreira PL; Centre for Health Studies and Research of the University of Coimbra (CEISUC), Faculty of Economics, University of Coimbra, Coimbra, Portugal.
Saleh M; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Tamargo C; Department of Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
Quinn GP; Departments of Obstetrics and Gynecology and Population Health, Grossman School of Medicine, New York University, New York, NY, USA.
Źródło:: The oncologist [Oncologist] 2022 Mar 11; Vol. 27 (3), pp. e251-e264.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
Język:: English
Imprint Name(s):: Publication: 2022- : Oxford : Oxford University Press
Original Publication: Dayton, Ohio : AlphaMed Press, c1996-
MeSH Terms:: Fertility Preservation*/methods
Genital Neoplasms, Female*/complications
Genital Neoplasms, Female*/therapy
Female ; Fertility ; Gender Identity ; Humans ; Male ; Pregnancy ; Quality of Life
References:: Worldviews Evid Based Nurs. 2019 Oct;16(5):381-388. (PMID: 31149771)
BMC Cancer. 2018 Sep 6;18(1):874. (PMID: 30189847)
Fertil Steril. 2017 Sep;108(3):407-415.e11. (PMID: 28739117)
Obstet Gynecol Clin North Am. 2018 Sep;45(3):563-574. (PMID: 30092929)
Gynecol Oncol. 2005 May;97(2):310-7. (PMID: 15863123)
Cancer Med. 2020 Oct;9(20):7375-7380. (PMID: 32864852)
Crit Rev Oncol Hematol. 2016 Jan;97:206-19. (PMID: 26358422)
Semin Radiat Oncol. 2011 Jan;21(1):26-34. (PMID: 21134651)
Semin Oncol Nurs. 2019 Apr;35(2):202-210. (PMID: 30867103)
Cancer. 2015 Sep 1;121(17):2993-3000. (PMID: 26180029)
Am J Obstet Gynecol. 2020 Apr;222(4):330-337. (PMID: 31982386)
Cancer Med. 2021 Mar;10(5):1576-1588. (PMID: 33580749)
J Women Aging. 2020 May-Jun;32(3):329-348. (PMID: 30905277)
JAMA Netw Open. 2020 Jul 1;3(7):e2010806. (PMID: 32678451)
Radiol Clin North Am. 2020 Mar;58(2):401-412. (PMID: 32044014)
J Natl Cancer Inst Monogr. 2005;(34):94-8. (PMID: 15784834)
PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
J Cancer Surviv. 2017 Feb;11(1):58-63. (PMID: 27480882)
J Adolesc Young Adult Oncol. 2019 Jun;8(3):342-348. (PMID: 30585751)
Int J Nurs Stud. 2009 Apr;46(4):529-46. (PMID: 19233357)
Patient Educ Couns. 2016 Oct;99(10):1708-16. (PMID: 27234174)
Int J Gynecol Cancer. 2021 Mar;31(3):345-351. (PMID: 32565487)
Hum Reprod Update. 2014 Mar-Apr;20(2):279-92. (PMID: 24077938)
Gynecol Oncol. 2019 Dec;155(3):522-529. (PMID: 31604663)
J Gynecol Oncol. 2019 May;30(3):e45. (PMID: 30887762)
Hum Reprod Update. 2015 Jul-Aug;21(4):517-35. (PMID: 25958409)
Gynecol Oncol Res Pract. 2016 Jul 27;3:8. (PMID: 27468354)
Cancer Nurs. 2014 Jan-Feb;37(1):75-82. (PMID: 23486357)
J Clin Oncol. 2011 May 1;29(13):1670-7. (PMID: 21444865)
J Psychosoc Oncol. 2012;30(4):387-401. (PMID: 22747104)
Ecancermedicalscience. 2018 Jan 16;12:798. (PMID: 29434664)
Cancer. 2015 Nov 15;121(22):3938-47. (PMID: 26264701)
J Clin Oncol. 2018 Jul 1;36(19):1994-2001. (PMID: 29620997)
Hum Reprod Update. 2009 Sep-Oct;15(5):587-97. (PMID: 19433413)
Int J Nurs Stud. 2012 Jan;49(1):47-53. (PMID: 21835406)
Hum Reprod. 2019 Sep 29;34(9):1726-1734. (PMID: 31398258)
Contracept Reprod Med. 2017 Mar 02;2:12. (PMID: 29201417)
J Clin Oncol. 2012 Jun 10;30(17):2147-53. (PMID: 22585695)
Gynecol Oncol. 2017 Mar;144(3):631-636. (PMID: 28012689)
JMIR Cancer. 2019 Jun 6;5(1):e12593. (PMID: 31199289)
J Natl Cancer Inst Monogr. 2005;(34):91-3. (PMID: 15784833)
Fertil Steril. 2016 Dec;106(7):1763-1771.e1. (PMID: 27678034)
BJOG. 2016 Sep;123 Suppl 3:65-8. (PMID: 27627601)
Gynecol Oncol. 2010 Nov;119(2):358-65. (PMID: 20817227)
Breast Cancer Res Treat. 2009 Jul;116(2):215-23. (PMID: 19390962)
Hum Reprod Update. 2016 Apr;22(3):281-305. (PMID: 26759231)
Psychooncology. 2019 Mar;28(3):459-467. (PMID: 30523651)
JCO Glob Oncol. 2020 Mar 2;6:. (PMID: 32259159)
Hum Reprod Update. 2019 Mar 1;25(2):159-179. (PMID: 30462263)
J Support Oncol. 2012 Jul-Aug;10(4):160-5. (PMID: 22266153)
J Adolesc Young Adult Oncol. 2020 Aug;9(4):502-507. (PMID: 32255707)
Fertil Steril. 2010 Oct;94(5):1652-6. (PMID: 19945099)
J Cancer Surviv. 2010 Sep;4(3):236-46. (PMID: 20373042)
Contributed Indexing:: Keywords: attitudes; fertility; fertility counseling; fertility preservation; gynecological cancer; young women
Entry Date(s):: Date Created: 20220311 Date Completed: 20220420 Latest Revision: 20220420
Update Code:: 20240104
PubMed Central ID:: PMC8914481
DOI:: 10.1093/oncolo/oyab051
PMID:: 35274725
: Czasopismo naukowe

Full Text Finder

Background: Gynecologic cancers standard treatment often requires the removal of some reproductive organs, making fertility preservation a complex challenge. Despite heightened oncofertility awareness, knowledge about fertility attitudes and decisions of young patients with gynecologic cancer is scarce. The aim of this systematic review was to highlight what is currently known about knowledge, attitudes, and decisions about fertility, fertility preservation, and parenthood among these patients.
Methods: Peer-reviewed journals published in English were searched in PubMed, Web of Science and EMBASE from January 1, 2000 to July 1, 2020. Childbearing, fertility, fertility preservation, pregnancy, and parenthood attitudes/decisions after gynecologic cancer from women's perspective were evaluated.
Results: A total of 13 studies comprised the review. Most of the women valued fertility preservation procedures that could be regarded as a means to restore fertility. A unique feature identified was that fertility preservation was seen also as a way to restore gender identity perceived to be lost or threatened during diagnosis and treatment. Fertility counseling was suboptimal, with wide variability among studies reviewed. Comparisons between gynecologic cancers and other cancer types about fertility counseling rates were inconclusive. The potential negative impact of impaired fertility on patients' mental health and quality of life was also documented.
Conclusions: Fertility and parenthood were important matters in patients' lives, with the majority of patients expressing positive attitudes toward future childbearing. Results confirm that the inclusion of patients with gynecologic cancer in research studies focusing on this topic still remains low. Additionally, the provision of fertility counseling and referral by health professionals is still suboptimal.
(© The Author(s) 2022. Published by Oxford University Press.)

Informacja